Aspirin and breast cancer prevention--a link to ER status.
Tait
Catherine R
CR
Molecular Medicine Unit, Clinical Sciences Building, St James's University Hospital, Beckett Street, Leeds, UK. cathytait@doctors.org.uk
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000378:metabolism / Q000517:prevention & control*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016588:Anticarcinogenic Agents; D016861:Cyclooxygenase Inhibitors; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D001241:Aspirin